The RB2/p130 gene: The latest weapon in the war against lung cancer?

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 754-764

  Claudio, Pier Paolo ^a,b   Caputi, Mario ^b   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; CANCER RESEARCH; GENE TARGETING; GENE THERAPY; HUMAN; LUNG CARCINOMA; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SHORT SURVEY; SIMIAN VIRUS 40; TREATMENT INDICATION; TUMOR SUPPRESSOR GENE;

GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; PHOSPHOPROTEINS; PROTEINS; RETINOBLASTOMA-LIKE PROTEIN P130;

EID: 0034058076     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (166)

1. Carney, D. N. Lung cancer biology. Curr. Opin. Oncol., 3: 288-296, 1991.
2. Wiest, J. S., Franklin, W. A., Drabkin, H., Gemmill, R., Sidransky, D., and Anderson, M. W. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention. J. Cell. Biochem., 29 (Suppl.): 64-73, 1997
3. Todd, S., Franklin, W. A., Varella-Garcia, M., Kennedy, T., Hilliker, C. E., Jr., Hahner, L., Anderson, M., Wiest, J. S., Drabkin, H. A., and Gemmill, R. M. Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res., 57: 1344-1352, 1997.
4. Shimizu, E., and Sone, S. Tumor suppressor genes in human lung cancer. J. Med. Investig., 44: 15-24, 1997.
5. Virmani, A. K., Fong, K. M., Kodagoda, D., McIntire, D., Hung, J., Tonk, V., Minna, J. D., and Gazdar, A. F. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer, 21: 308-319, 1998.
6. D'Amico, D., Carbone, D. P., Johnson, B. E., Meltzer, S. J., and Minna, J. D. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res., 52: 1996-1999, 1992.
7. Ohata, H., Emi, M., Fujiwara, Y., Higashino, K., Nakagawa, K., Futagami, R., Tsuchiya, E., and Nakamura, Y. Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes Cancer, 7: 85-88, 1993.
8. Sato, S., Nakamura, Y., and Tsuchiya, E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res., 54: 5652-5655, 1994.
9. Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H., and Yokota, J. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res., 54: 5643-5648, 1994.
10. Bepler, G., and Garcia-Blanco, M. A. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 5513-5517, 1994.
11. Otsuka, T., Kohno, T., Mori, M., Noguchi, M., Hirohashi, S., and Yokota, J. Deletion mapping of chromosome 2 in human lung carcinoma. Genes Chromosomes Cancer, 16: 113-119, 1996.
12. O'Briant, K. C., and Bepler, G. Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B. Genes Chromosomes Cancer, 18: 111-114, 1997.
13. Brambilla, E., and Brambilla, C. p53 and lung cancer. Pathol. Biol., 45: 852-863, 1997.
14. Sekido, Y., Fong, K. M., and Minna, J. D. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta, 1378: F21-F59, 1998.
15. Demoly, P., Pujol, J. L., Godard, P., and Michel, F. B. Oncogenes and anti-oncogenes in lung cancer. Presse Med., 23: 291-297, 1994.
16. Salgia, R., and Skarin, A. T. Molecular abnormalities in lung cancer. J. Clin. Oncol., 16: 1207-1217, 1998.
17. Ferron, P. E., Bagni, I., Guidoboni, M., Beccati, M. D., and Nenci, I. Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions. Tumori, 83: 587-593, 1997.
18. Gazdar, A. F. The molecular and cellular basis of human lung cancer. Anticancer Res., 14: 261-267, 1994.
19. Dosaka-Akita, H., Hu, S. X., Fujino, M., Harada, M., Kinoshita, I., Xu, H. J., Kuzumaki, N., Kawakami, Y., and Benedict, W. F. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer (Phila.), 79: 1329-1337, 1997.
20. Lee, C. T. Non-surgical therapy for the patients with advanced non-small cell lung cancer. Respirology, 3: 159-166, 1998.
21. Stratford-Perricaudet, L. D., Levrero, M., Chasse, J. F., Perricaudet, M., and Briand, P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther., 1: 241-256, 1990.
22. Romano, G., Claudio, P. P., Kaiser, H. E., and Giordano, A. Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery m therapy. In Vivo, 12: 59-67, 1998.
23. Giordano, A., and Romano, G. Gene therapy: where are we going? La Clinica Terapeutica, 150: 3-4, 1999.
24. Schuler, M., Rochlitz, C., Horowitz, J. A., Schlegel, J., Perruchoud, A. P., Kommoss, F., Bolliger, C. T., Kauczor, H. U., Dalquen, P., Fritz, M. A., Swanson, S., Herrmann, R., and Huber, C. A Phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum. Gene Ther., 9: 2075-2082, 1998.
25. Roth, J. A., Swisher, S. G., Merritt, J. A., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., El-Naggar, A. K., Fossella, F. V., Glisson, B. S., Hong, W. K., Khurl, F. R., Kune, J. M., Nesbitt, J. C., Pisters, K., Putnam, J. B., Schrump, D. S., Shin, D. M., and Walsh, G. L. Gene therapy for non-small cell lung cancer: a preliminary report of a Phase I trial of adenoviral p53 gene replacement. Semin. Oncol., 25: 33-37, 1998.
26. Lee, J. H., Lee, C. T., Yoo, C. G., Hong, Y. K., Kim, C. M., Han, S. K., Shim, Y. S., Carbone, D. P., and Kim, Y. W. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line. Anticancer Res., 18: 3257-3261, 1998.
27. Coll, J. L., Negoescu, A., Louis, N., Sachs, L., Tenaud, C., Girardot, V., Demeinex, B., Brambilla, E., Brambilla, C., and Favrot, M. Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis. Hum. Gene Ther., 9: 2063-2074, 1998.
28. Zou, Y., Zong, G., Ling, Y. H., Hao, M. M., Lozano, G., Hong, W. K., and Perez-Soler, R. Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes [see comments]. J. Natl. Cancer Inst., 90: 1130-1137, 1998.
29. Joshi, U. S., Chen, Y. Q., Kalemkerian, G. P., Adil, M. R., Kraut, M., and Sarkar, F. H. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther., 5: 183-191, 1998.
30. Zhang, W. W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 5-13, 1994.
31. Cournoyer, D., and Caskey, C. T. Gene therapy of the immune system. Annu. Rev. Immunol., 11: 297-329, 1993.
32. Gilboa, E. Retroviral gene transfer: applications to human therapy. Prog. Clin. Biol. Res., 352: 301-311, 1990.
33. Kohn, D. B., Anderson, W. F., and Blaese, R. M. Gene therapy for genetic diseases. Cancer Investig., 7: 179-192, 1989.
34. Miller, A. D. Retrovirus packaging cells. Hum. Gene Ther., 1: 5-14, 1990.
35. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA. 93: 11382-11388, 1996.
36. Naldini, L., Blomer, U., Gallay, P , Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science (Washington DC), 272: 263-267, 1996.
37. Poeschla, E., Corbeau, P., and Wong-Staal, F. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA, 93: 11395-11399, 1996.
38. Srinivasakumar, N., Chazal, N., Helga-Maria, C., Prasad, S., Hammarskjold, M. L., and Rekosh, D. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol., 71: 5841-5848, 1997.
39. Stewart, P. L., Burnett, R. M., Cyrklaff, M., and Fuller, S. D. Image reconstruction reveals the complex molecular organization of adenovirus. Cell, 67: 145-154, 1991.
40. Ballay, A., Levrero, M., Buendia, M. A., Tiollais, P., and Perricaudet, M. In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses. EMBO J., 4: 3861-3865, 1985.
41. Yamada, M., Lewis, J. A., and Grodzicker, T. Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector. Proc. Natl. Acad. Sci. USA, 82: 3567-3571, 1985.
42. Lemarchand, P., Jaffe, H. A., Danel, C., Cid, M. C., Kleinman, H. K., Stratford-Perricaudet, L. D., Perricaudet, M., Pavirani, A., Lecocq, J. P., and Crystal, R. G. Adenovirus-mediated transfer of a recombinant human α 1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA, 89: 6482-6486, 1992.
43. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell, 68: 143-155, 1992.
44. Blacklow, N. R., Hoggan, M. D., Kapikian, A. Z., Austin, J. B., and Rowe, W. P. Epidemiology of adenovirus-associated virus infection in a nursery population. Am. J. Epidemiol., 88: 368-378, 1968.
45. Berns, K. I., Pinkerton, T. C., Thomas, G. F., and Hoggan, M. D. Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology, 68: 556-560, 1975.
46. Cheung, A. K., Hoggan, M. D., Hauswirth, W. W., and Berns, K. I. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Viral., 33: 739-748, 1980.
47. Podsakoff, G., Wong, K. K., Jr., and Chatterjee, S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol., 68: 5656-5666, 1994.
48. Kotin, R. M., and Berns, K. I. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology, 170: 460-467, 1989.
49. Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., and Berns, K. I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA. 87: 2211-2215, 1990.
50. Kotin, R. M., Linden, R. M., and Berns, K. I. Characterization of a preferred site on human chromosome 19q for integration of adenoassociated virus DNA by non-homologous recombination. EMBO J., 11: 5071-5078, 1992.
51. Kotin, R. M., Menninger, J. C., Ward, D. C., and Berns, K. I. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics, 10: 831-834, 1991.
52. Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N , and Hunter, L. A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 [published erratum appears in EMBO J., 11: 1228, 1992]. EMBO J., 10: 3941-3950, 1991.
53. Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N , and Hunter, L. A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 [published erratum appears in EMBO J., 11: 1228, 1992]. EMBO J., 10: 3941-3950, 1991.
54. Russell, D. W., Miller, A. D., and Alexander, I. E. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA, 91: 8915-8919, 1994.
55. Strayer, D. S., and Milano, J. SV40 mediates stable gene transfer in vivo. Gene Ther., 3: 581-587, 1996.
56. Strayer, D. S. SV40 as an effective gene transfer vector in vivo. J. Biol. Chem., 271: 24741-24746, 1996.
57. Strayer, D. S., Kondo, R., Milano, J., and Duan, L. X. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Ther., 4: 219-225, 1997.
58. Glorioso, J., Bender, M. A., Fink, D., and DeLuca, N. Herpes simplex virus vectors. Mol. Cell. Biol. Hum. Dis., 5: 33-63, 1995.
59. Glorioso, J. C., Bender, M. A., Coins, W. F., Fink, D. J., and DeLuca, N. HSV as a gene transfer vector for the nervous system. Mol. Biotechnol., 4: 87-99, 1995.
60. Glorioso, J. C., DeLuca, N. A., and Fink, D. J. Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol., 49: 675-710, 1995.
61. Mocarski, E. S., Kemble, G. W., Lyle, J. M., and Greaves, R. F. A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc. Natl. Acad. Sci. USA, 93: 11321-11326, 1996.
62. Robertson, E. S., Ooka, T., and Kieff, E. D. Epstein-Barr virus vectors for gene delivery to B lymphocytes. Proc. Natl. Acad. Sci. USA, 93: 11334-11340, 1996.
63. Paoletti, E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA. 93: 11349-11353, 1996.
64. Moss, B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA, 93: 11341-11348, 1996.
65. Palese, P., Zheng, H., Engelhardt, O. G., Pleschka, S., and Garcia-Sastre, A. Negative-strand RNA viruses: genetic engineering and applications. Proc. Natl. Acad. Sci. USA, 93: 11354-11358, 1996.
66. Frolov, I., Hoffman, T. A., Pragai, B. M., Dryga, S. A., Huang, H. V., Schlesinger, S., and Rice, C. M. α-virus-based expression vectors: strategies and applications. Proc. Natl. Acad. Sci. USA, 93: 11371-11377, 1996.
67. Duboise, S. M., Guo, J., Desrosiers, R. C., and Jung, J. U. Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses. Proc. Natl. Acad. Sci. USA, 93: 11389-11394, 1996.
68. Thierry, A. R., and Dritschilo, A. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res., 20: 5691-5698, 1992.
69. Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E., and Mirabelli, C. K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol., 41: 1023-1033, 1992.
70. Thierry, A. R., Rahman, A., and Dritschilo, A. Overcoming multi-drug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem. Biophys. Res. Commun., 190: 952-960, 1993.
71. Ryser, H. J., and Shen, W. C. Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc. Natl. Acad. Sci. USA, 75: 3867-3870, 1978.
72. Bayard, B., Bisbal, C., and Lebleu, B. Activation of ribonuclease L by (2′-5′)(A)4-poly(L-lysine) conjugates in intact cells. Biochemistry, 25: 3730-3736, 1986.
73. Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction [see comments]. N. Engl. J. Med., 323: 570-578, 1990.
74. Osanto, S , Brouwenstyn, N., Vaessen, N., Figdor, C. G., Melief, C. J., and Schrier, P. I. Immunization with interleukin-2 transfected melanoma cells. A Phase I-II study in patients with metastatic mela-noma. Hum. Gene Ther., 4: 323-330, 1993.
75. Arienti, F., Sule-Suso, J., Belli, F., Mascheroni, L., Rivoltini, L., Melani, C., Maio, M., Cascinelli, N., Colombo, M. P., and Parmiani, G. Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells. Hum. Gene Ther., 7: 1955-1963, 1996.
76. Nabel, G. J., Gordon, D., Bishop, D. K., Nickoloff, B. J., Yang, Z. Y., Aruga, A., Cameron, M. J , Nabel, E. G., and Chang, A. E. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibdity complex gene with DNA-liposome complexes. Proc. Natl. Acad. Sci. USA, 93: 15388-15393, 1996.
77. Stopeck, A. T , Hersh, E. M., Akporiaye, E. T., Harris, D. T., Grogan, T., Unger, E., Warneke, J., Schluter, S. F., and Stahl, S. Phase I study of direct gene transfer of an allogeneic histocompatibility anti-gen, HLA-B7, in patients with metastatic melanoma, J. Clin. Oncol., 15: 341-349, 1997.
78. Nguyen, D. M., Spitz, F. R., Yen, N., Cristiano, R. J., and Roth, I. A. Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J. Thorac. Cardiovasc. Surg., 112: 1372-1376; discussion, 1376-1377, 1996.
79. Shinnick, T. M., Lerner, R. A., and Sutcliffe, J. G. Nucleotide sequence of Moloney marine leukaemia virus. Nature (Lond.), 293: 543-548, 1981.
80. Sutcliffe, J. G., Shinnick, T. M., Verma, I. M., and Lerner, R. A. Nucleotide sequence of Moloney leukemia virus: 3′ end reveals details of replications, analogy to bacterial transposons, and an unexpected gene. Proc. Natl. Acad. Sci. USA. 77: 3302-3306, 1980
81. Sutcliffe, J. G., Shinnick, T. M., and Lerner, R. A. Moloney murine leukemia virus is a transposon: nucleotide sequence analysis identifies genes and replication details. Cold Spring Harbor Symp. Quant. Biol., 45: 707-710, 1981.
82. Takeuchi, Y., Cosset, F. L., Lachmann, P. J., Okada, H., Weiss, R. A., and Collins, M. K. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol., 68: 8001-8007, 1994.
83. Landau, N. R., and Littman, D. R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol., 66: 5110-5113, 1992.
84. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA, 90: 8392-8396, 1993.
85. Finer, M. H., Dull, T. J., Qin, L., Farson, D., and Roberts, M. R. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood, 83: 43-50, 1994.
86. Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., and Kingsman, A. J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res., 23: 628-633, 1995.
87. Rowe, W. P., Huebner, R. J., Gilmore, L. K., Parrot, R. H., and Ward, T. G. Isolation of a cytopathogenetic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med., 84: 570-573, 1953.
88. Cristiano, R. J., Xu, B., Nguyen, D., Schumacher, G., Kataoka, M., Spitz, F. R., and Roth, J. A. Viral and nonviral gene delivery vectors for cancer gene therapy. Cancer Detect. Prev., 22: 445-454, 1998.
89. Yei, S., Mittereder, N., Tang, K., O'Sullivan, C., and Trapnell, B. C. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther., 1: 192-200, 1994.
90. Pierzchalski, P., Reiss, K., Cheng, W., Cirielli, C., Kajstura, J., Nitahara, J. A., Rizk, M., Capogrossi, M. C., and Anversa, P. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp. Cell Res., 234: 57-65, 1997.
91. Liu, G., Excoffon, K. J., Benoit, P., Ginzinger, D. G., Miao, L., Ehrenborg, E., Duverger, N., Denefle, P. P., Hayden, M. R., and Lewis, M. E. Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells. Hum. Gene Ther., 8: 205-214, 1997.
92. van Esseveldt, K. E., Hermens, W. T., Verhaagen, J., and Boer, G. J. Transgene expression in rat fetal brain grafts is maintained for 7 months after ex vivo adenoviral vector-mediated gene transfer. Neurosci. Lett., 240: 116-120, 1998.
93. Hermens, W. T., Giger, R. J., Holtmaat, A. J., Dijkhuizen, P. A., Houweling, D. A., and Verhaagen, J. Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS. J. Neurosci. Methods, 71: 85-98, 1997.
94. Caruso, M., Pham-Nguyen, K., Kwong, Y. L., Xu, B., Kosai, K. I., Finegold, M., Woo, S. L., and Chen, S. H. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma Proc. Natl. Acad. Sci. USA, 93: 11302-11306, 1996.
95. Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C. S., Mastrangeli, A., Hay, J. G., Brody,. S L., Jaffe, H. A., Eissa, N. T., and Danel, C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis [see comments]. Nat. Genet., 8: 42-51, 1994.
96. Crystal, R. G., Jaffe, A., Brody, S., Mastrangeli, A., McElvaney, N. G., Rosenfeld, M., Chu, C. S., Danel, C., Hay, J., and Eissa, T. A Phase I study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum. Gene Ther., 6: 643-666, 1995.
97. Gahery-Segard, H., Molinier-Frenkel, V., Le Boulaire, C., Saulnier, P., Opolon, P., Lengagne, R., Gautier, E., Le Cesne, A., Zitvogel, L., Venet, A., Schatz, C., Courtney, M., Le Chevalier, T., Tursz, T., Guillet, J. G., and Farace, F. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J. Clin. Investig., 100: 2218-2226, 1997.
98. Kass-Eisler, A., Leinwand, L., Gall, J., Bloom, B., and Falck-Pedersen, E Circumventing the immune response to adenovirus-mediated gene therapy. Gene Ther., 3: 154-162, 1996.
99. Vilquin, J. T., Guerette, B., Kinoshita, I., Roy, B., Goulet, M., Gravel, C., Roy, R., and Tremblay, J. P. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther., 6: 1391-1401, 1995.
100. Berns, K. I., and Linden, R. M. The cryptic life style of adenoassociated virus. Bioessays, 17: 237-245, 1995.
101. Xiao, X., Li, J., and Samulski, R. J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol., 70: 8098-8108, 1996.
102. Schimmenti, S., Boesen, J., Claassen, E. A., Valerio, D., and Einerhand, M P. Long-term genetic modification of rhesus monkey hematopoietic cells following transplantation of adeno-associated virus vector-transduced CD34+ cells. Hum. Gene Ther., 9: 2727-2734, 1998.
103. Zhang, P. X., and Fuleihan, R. L. Transfer of activation-dependent gene expression into T cell lines by recombinant adeno-associated virus. Gene Ther., 6: 182-189, 1999.
104. Lo, W. D., Qu, G., Sferra, T. J., Clark, R., Chen, R., and Johnson, P. R. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum. Gene Ther., 10: 201-213, 1999.
105. Monahan, P. E., Samulski, R. J., Tazelaar, J., Xiao, X., Nichols, T. C., Bellinger, D. A., Read, M. S., and Walsh, C. E. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther., 5: 40-49, 1998.
106. Dong, J. Y., Fan, P. D., and Frizzell, R. A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther., 7, 2101-2112, 1996.
107. Teramoto, S., Bartlett, J. S., McCarty, D., Xiao, X., Samulski, R. J., and Boucher, R. C. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors. J. Virol., 72: 8904-8912, 1998.
108. Samulski, R. J., Chang, L. S., and Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol., 63: 3822-3828, 1989.
109. Xiao, X., Li, J., and Samulski, R. J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol., 72: 2224-2232, 1998.
110. Strayer, D. Gene therapy using SV40-derived vectors: what does the future hold? J. Cell. Physiol., 181, 375-384, 1999.
111. De Luca, A., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., Carbone, M., and Giordano, A The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas [see comments]. Nat. Med., 3: 913-916, 1997.
112. Carbone, M , Rizzo, P., Grimley, P. M., Procopio, A., Mew, D. J., Shridhar, V., de Bartolomeis, A., Esposito, V.. Giuliano, M. T., Steinberg, S. M., Levine, A. S., Giordano, A., and Pass, H. I. Simian virus-40 large-T antigen binds p53 in human mesotheliomas [see comments]. Nat. Med., 3: 908-912, 1997.
113. Cicala, C., Pompetti, F , and Carbone, M. SV40 induces mesotheliomas in hamsters. Am. J. Pathol., 142: 1524-1533, 1993.
114. Carbone, M., Rizzo, P., Procopio, A., Giuliano, M., Pass, H. I., Gebhardt, M. C., Mangham, C., Hansen, M., Malkin, D. F., Bushan, G., Pompetti, F., Picci, P., Levine, A. S., Bergsagel, J. D , and Garcea, R. L. SV40-like sequences in human bone tumors. Oncogene, 13: 527-535, 1996.
115. Lednicky, J. A., Garcea, R. L., Bergsagel, D. J., and Butel, J. S. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology, 212: 710-717, 1995.
116. Mortimer, E. A., Jr., Lepow, M. L., Gold, E., Robbins, F. C., Burton. G. J., and Fraumeni, J. F., Jr. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N. Engl. J. Med., 305: 1517-1518, 1981.
117. Shah, K., and Nathanson, N. Human exposure to SV40: review and comment. Am. J. Epidemiol., 103: 1-12, 1976.
118. Geissler, E. SV40 and human brain tumors. Prog. Med. Virol., 37: 211-222, 1990.
119. Geissler, E., and Staneczek, W. SV40 and human brain tumors. Arch. Geschwulsrforsch., 58: 129-134, 1988.
120. Strickler, H. D., Rosenberg, P. S., Devesa, S. S., Hertel, J., Fraumeni, J. F., Jr., and Goedert, J. J. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates [see comments]. J. Am. Med. Assoc., 279: 292-295, 1998.
121. Fang, B., Koch, P., Bouvet, M., Ji, L., and Roth, J. A. A packaging system for SV40 vectors without viral coding sequences. Anal. Biochem., 254: 139-143, 1997.
122. Sandalon, Z., Dalyot-Herman, N., Oppenheim, A. B., and Oppenheim, A. In vitro assembly of SV40 virions and pseudovirions: vector development for gene therapy. Hum. Gene Ther., 8: 843-849, 1997.
123. Batra, R. K., Olsen, J. C., Pickles, R. J., Hoganson, D. K., and Boucher, R. C. Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors. Am. J. Respir. Cell Mol. Biol., 18: 402-410, 1998.
124. Dubinett, S. M., Miller, P. W., Sharma, S., and Batra, R. K. Gene therapy for lung cancer. Hematol. Oncol. Clin. N. Am., 12: 569-594, 1998.
125. Fink, D. J., Ramakrishnan, R., Marconi, P., Goins, W. F., Holland, T. C., and Glorioso, J. C. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system. Clin. Neurosci., 3: 284-291, 1995.
126. Howard, C. M., Claudio, P. P., Gallia, G. L., Gordon, J., Giordano, G. G., Hauck, W. W., Khalili, K., and Giordano, A. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo [see comments]. J. Natl. Cancer Inst., 90: 1451-1460, 3998.
127. Hwang, H. C., Smythe, W. R., Elshami, A. A., Kucharczuk, J C., Amin, K. M., Williams, J. P., Litzky, L. A , Kaiser, L. R., and Albelda, S. M. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am. J. Respir. Cell Mol. Biol., 13: 7-16, 1995.
128. Kondo, R., Feitelson, M. A., and Strayer, D. S Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent. Gene Ther., 5: 575-582, 1998.
129. Nguyen, D. M., Wiehle, S. A., Roth, J. A., and Cristiano, R. J. Gene delivery into malignant cells in vivo by a conjugated adenovirus/ DNA complex. Cancer Gene Ther., 4: 183-190, 1997.
130. Nguyen, D. M., Wiehle, S. A., Koch, P. E., Branch, C., Yen, N., Roth, J. A., and Cristiano. R. J. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Cancer Gene Ther., 4, 191-198, 1997.
131. Roth, J. A. Gene replacement strategies for lung cancer. Curr. Opin. Oncol., 10: 127-132, 1998.
132. Sahenk, Z., Seharaseyon, J., Mendell, J. R., and Burghes, A. H. Gene delivery to spinal motor neurons. Brain Res., 606: 126-129, 1993.
133. Tursz, T., Cesne, A. L., Baldeyrou, P., Gautier, E., Opolon, P., Schatz, C., Pavirani, A., Courtney, M., Lamy, D., Ragot, T., Saulnier, P., Andremont, A., Monier, R., Perricaudet, M., and Le Chevalier, T. Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J. Natl Cancer Inst., 88: 1857-1863, 1996.
134. Malkinson, A. M. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res., 24: 541-555, 1998.
135. Roth, J. A. Restoration of rumor suppressor gene expression for cancer. Forum, (Genova) 8: 368-376, 1998.
136. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Person, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C. I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer [see comments]. Nat. Med., 2: 985-991, 1996.
137. Santoso, J. T., Tang, D. C., Lane, S. B., Hung, J., Reed, D. J., Muller, C. Y., Carbone, D. P., Lucci, J. A., III, Miller, D. S., and Mathis, J. M. Adenovirus-based p53 gene therapy in ovarian cancer [see comments]. Gynecol. Oncol., 59: 171-178, 1995.
138. Goodrich, D. W., Wang, N. P., Qian, Y. W., Lee, E. Y., and Lee, W. H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell, 67: 293-302, 1991.
139. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
140. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., and Ullrich, S. J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
141. Carbone, D. P., and Minna, J. D. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus [see comments]. J. Natl. Cancer Inst., 86: 1437-1438, 1994.
142. Dunst, J. Gene therapy with wild-type p53 in lung tumors. Strahlenther. Onkol., 173: 431-432, 1997.
143. Riley, D. J., Nikitin, A. Y , and Lee, W. H. Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb+/- mice. Nat. Med., 2: 1316-13121, 1996.
144. Fueyo, J., Gomez-Manzano, C., Yung, W. K., Liu, T. J., Alemany, R., Bruner, J. M., Chintala, S. K., Rao, J. S., Levin, V. A., and Kyritsis, A. P. Suppression of human glioma growth by adenovirus-mediated Rb gene transfer [see comments]. Neurology, 50: 1307-1315, 1998.
145. Lefebvre, D., Gala, J. L., Heusterspreute, M., Delhez, H., and Philippe, M. Introduction of a normal retinoblastoma (Rb) gene into Rb-deficient lymphoblastoid cells delays tumorigenicity in immunodefective mice. Leuk. Res , 22: 905-912, 1998.
146. Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., and Harlow, E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev., 7: 1111-1125, 1993.
147. Claudio, P. P., Howard, C. M., Baldi, A., De Luca, A., Fu, Y., Condorelli, G., Sun, Y., Colburn, N., Calabretta, B., and Giordano, A. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p 107. Cancer Res., 54: 5556-5560, 1994.
148. Pupa, S., Howard, C. M., Invernizzi, A. M., De Vecchi, R., Giani, C., Claudio, P. P., Colnaghi, M. I., Giordano, A., and Menard, S. Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the erb-2-overexpressing SKOV3 tumor cell line. Oncogene, 18: 651-656, 1999.
149. Claudio, P. P., Howard, C. M., Pacilio, C., Cinti, C., Romano, G., Minimo, C., Maraldi, N. M., Minna, J. D., Gelbert, L., Micheli, P., Leoncini, L., Tosi, G. M., Caputi, M., Giordano, G. G., and Giordano, A. Suppression of tumor growth in vivo by retroviral-mediated retinoblastoma-related RB2/p130 gene transfer. Cancer Res., 60: 372-382, 2000.
150. Yeung, R. S., Bell, D. W., Testa, J. R., Mayol, X., Baldi, A., Grana, X., Klinga-Levan, K., Knudson, A. G., and Giordano, A. The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene, 8: 3465-3468, 1993.
151. Minimo, C., Bibbo, M., Claudio, P. P., De Luca, A., and Giordano, A. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies. Pathol. Res. Pract., 195: 67-70, 1999.
152. Baldi, A., Esposito, V., De Luca, A., Fu, Y., Meoli, L. Giordano, G. G., Caputi, M., Baldi, F., and Giordano, A. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin. Cancer Res., 3: 1691-1697, 1997.
153. Baldi, A., Esposito, V., De Luca, A., Howard, C. M., Mazzarella, G., Baldi, F., Caputi, M., and Giordano, A. Differential expression of the retinoblastorna gene family members pRb/p105, p107, and pRb2/p130 in lung cancer. Clin. Cancer Res., 2: 1239-1245, 1996.
154. Susini, T., Baldi, F., Howard, C. M., Baldi, A., Taddei, G., Massi, D., Rapi, S., Savino, L., Massi, G., and Giordano, A. Expression of the retinoblastoma-related Rb2/p130 correlates with clinical outcome in endometrial cancer. J. Clin. Oncol., 16: 1085-1093, 1998.
155. Leoncini, L., Bellan, C., Cossu, A., Claudio, P. P., Lazzi, S., Cinti, C., Cevenini, G., Megha, T., Laurini, L., Luzi, P., Fraternali Orcioni, G., Piccioli, M., Pileri, S., Giardino, C., Tosi, P., and Giordano, A. Retinoblastoma related p107 and pRb2/p130 proteins in malignant lymphomas. Distinct mechanism of cell growth control. Clin. Cancer Res., 5: 4065-4072, 1999.
156. Massaro-Giordano, M., Baldi, G., Baldi, A., and Giordano, A. Differential expression of the retinoblastoma gene family members in choroidal melanoma: prognostic significance. Clin. Cancer Res., 5: 1455-1458, 1999.
157. Helin, K., Holm, K., Niebuhr, A., Eiberg, H., Tommerup, N., Hougaard, S., Poulsen, H. S., Spang-Thomsen, M., and Norgaard, P. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc. Natl. Acad. Sci. USA, 94: 6933-6938, 1997.
158. Claudio, P. P., Howard, C. M., Fu, Y., Califano, L., Micheli, P., Mercer,
159. Cinti, C., Leoncini, L., Nyongo, A., Ferrari, F., Lazzi, S., Bellan, C., Zamparelli, A., Claudio, P. P., Maraldi, N. M., Giordano, A., and Tosi, P. Genetic alterations of the retinoblastoma related gene RB2/p130 identify different pathogenetic mechanism in and among Burkitt's lymphoma subtypes. Am. J. Pathol., in press, 1999.
160. Cinti, C., Claudio, P. P., Howard, C. M., Neri, L. M., Fu, Y., Leoncini, L., Tost, P., Maraldi, N. M., and Giordano, A. Genetic alterations disrupting the nuclear localization of the retinoblastoma related gene RB2/p130 in human cell lines and primary tumors. Cancer Res., 60: 383-389, 2000.
161. Pass, H. I., Donington, J. S., Wu, P., Rizzo, P., Nishimura, M., Kennedy, R., and Carbone, M. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J. Thorac. Cardiovasc. Surg., 116: 854-859, 1998.
162. Pass, H., Rizzo, P., Donington, J., Wu, P., and Carbone, M. Further validation of SV40-like DNA in human pleural mesotheliomas. Dev. Biol. Stand., 94: 143-145, 1998.
163. Fattaey, A. R., Harlow, E., and Helin, K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol., 13: 7267-7277, 1993.
164. Vousden, K. H. Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol., 6: 1995.
165. Anderson, M., Sladon, S., Michels, R., Davidson, L., Conwell, K., II, Lechner, J., Franklin, W., Saccomanno, G., and Wiest, J. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma. J. Cell. Biochem., 25 (Suppl.). 185-190, 1996.
166. Carney, D. N. Oncogenes and genetic abnormalities in lung cancer. Chest, 96: 25S-27S, 1989.